Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04235582 · ClinicalTrials.gov registry record · NA

Incentives to Decrease Opioid Use - Pilot

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT04235582 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04235582, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

The purpose of this study is to address two key questions in the literature on incentives for substance use. The first question is whether it is more effective to directly incentivize the outcome of interest - drug abstinence - or to incentivize behaviors that are inputs into the production of abstinence. This study will compare two versions of the incentive program: one that incentivizes inputs to achieving abstinence and one that incentivizes the outcome of abstinence. The second question is how to optimize the size of incentives over time to maximize incentive effectiveness. This will be done by randomly varying the size and timing of incentives offered to participants in both the Inputs and Outcomes groups. The incentive amounts will then be varied across participants and time to fit a structural model of abstinence behaviors over time. The model will be used to describe the optimal shape of incentives over time.

Interventions

  • BEHAVIORAL App + Inputs Contingency Management
  • BEHAVIORAL App + Outcomes Contingency Management

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2020-08-25
Est. Completion 2021-05-15
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04235582

The ClinicalTrials.gov registry entry for NCT04235582 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which App + Inputs Contingency Management is the first listed.

NCT04235582 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04235582 about?

NCT04235582 is a clinical study titled "Incentives to Decrease Opioid Use - Pilot". The purpose of this study is to address two key questions in the literature on incentives for substance use. The first question is whether it is more effective to directly incentivize the outcome of interest - drug abstinence - or to incentivize behaviors that are inputs into the production of absti...

What is the current status of trial NCT04235582?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2020-08-25. Estimated completion is 2021-05-15.

What interventions are being tested in trial NCT04235582?

The interventions under investigation include: App + Inputs Contingency Management (BEHAVIORAL), App + Outcomes Contingency Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04235582?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.